Aphyren Capsule  contains an active component as acebrophylline. It is a medication used to manage respiratory conditions such as bronchial asthma and chronic obstructive pulmonary disease (COPD). It can alleviate symptoms associated with respiratory conditions, such as wheezing, coughing, shortness of breath, and chest tightness. Improving bronchodilation and reducing airway inflammation can help individuals experience fewer and less severe symptoms. This medication has improved lung function parameters such as forced expiratory volume in one second (FEV1) and peak expiratory flow rate (PEFR). These improvements indicate better respiratory function and can contribute to overall lung health. Aphyren Capsule is often used with other respiratory medications, such as inhaled bronchodilators and corticosteroids. It can complement the effects of these medications and provide additional benefits regarding bronchodilation and mucus clearance. This medication should not be used in individuals with known hypersensitivity or allergy to Aphyren Capsule, theophylline, ambroxol, or other medication components. This medication can cause an increase in blood pressure. It should be used cautiously in individuals with uncontrolled hypertension (high blood pressure) or severe cardiovascular and renal disease patients. It is contraindicated in individuals with a history of seizures or seizure disorders, as well as those who are at a high risk of developing seizures. Aphyren Capsule is generally not recommended for use in infants under the age of 12 months due to limited safety and efficacy data in this age group.